The Weekly Roundup: January 27–31

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

What’s New in the Medicine Chest: Seborrheic Dermatitis

James Del Rosso, DO, shared insights on existing and upcoming therapies for seborrheic dermatitis.

Exploring Facial Aesthetic Trends and Innovations Following Medication-Driven Weight Loss

Galderma's Gerry Muhle addresses facial aesthetic needs linked to weight loss, focusing on personalized, regenerative treatments.

Enhancing Patient Care Through Innovation

Noor noted patients benefit from in-house injection services, avoiding the inconvenience of traveling to off-site centers.

Nickel is the Most Prevalent Allergen in Pediatric Patients With and Without Atopic Dermatitis

A new review highlights overall allergen rates among children in the United States between 2010 and 2024.

Optimizing Aesthetic Outcomes for Patients on Medication-Driven Weight Loss Journeys

A new study explores an effective treatment protocol to restore volume and improve skin quality in patients experiencing facial changes from weight loss medications.

2025 Goals and Priorities of The Skin Cancer Foundation: An Interview with Executive Director, Becky Kamowitz

One of the Foundation’s top initiatives is its mobile skin cancer screening program, “Destination Healthy Skin.”

Reviewing Complex Cases: Concomitant PsO and PsA

At the Horizons in Advanced Practice meeting, Douglas DiRuggiero, DMSc, MHS, PA-C, presented a case of a man aged 47 years with a history of moderate psoriasis for 3 years and a recent diagnosis of psoriatic arthritis.

Galderma’s Innovations in Regenerative Aesthetics: Insights from Gerry Muhle

Muhle shares Galderma's study results on Sculptra and Restylane, showcasing regenerative aesthetics and personalized HIT treatments.

What’s New in the Medicine Chest: Acne Vulgaris

As a part of his presentation at Winter Clinical Miami, Del Rosso discussed new and emerging therapies for acne vulgaris.

Pilot Study Finds Intradermal Botulinum Toxin A Safe and Effective for Melasma

Investigators observed lowered MASI and PGA scores in the side of the face treated with BoNT-A.

Resources for Patients and Clinicians from the Skin Cancer Foundation

The Foundation’s extensive library includes brochures, magazines, and posters to promote education among dermatologists and patients.

What’s New in the Medicine Cabinet: AD and Ocular Comorbidities

James Del Rosso, DO, explored the treatment landscape and the importance of regular eye exams for patients with AD.

Advancing Aesthetics: Innovations, Trends, and Patient-Centric Strategies in the Era of Weight Loss Medications

Discover insights from Gerry Muhle and Michael Somenek, MD, on regenerative aesthetics, weight-loss impacts, and trends shaping facial rejuvenation.

Interview Intersection: Expert Interviews From January 2025

Dermatology Times is recapping our top expert interviews from the month of January.

Real-World Data Supports Dupilumab for Prurigo Nodularis Treatment in China

85% of Chinese PN patients saw a PP-NRS improvement of ≥ 4 points after 12 weeks of treatment.

Spearheading Awareness Campaigns for Skin Cancer Prevention and Sun Protection

“The Big See” campaign and the Seal of Recommendation program are just 2 examples of initiatives led by the Skin Cancer Foundation.

Review Finds HA Fillers Improve Skin Radiance

The meta-analysis found that HA fillers enhance skin hydration and glow, but do not significantly impact elasticity.

What’s New in the Medicine Chest: Granuloma Annulare

In an interview with Dermatology Times, Del Rosso gave insight on off-label therapies that could be used to treat granuloma annulare.

Merz Aesthetics Publishes Results of Global Confidence Study

The Pillars of Confidence global study assessed the role that confidence plays in daily life and how aesthetic treatments affect confidence.

What’s New in the Medicine Chest: Hailey-Hailey Disease

Del Rosso outlined new and off-label therapies for the disease that he shared in his presentation at Winter Clinical Miami.

Dermatology Times January 2025 Recap

Dermatology Times is looking back on the top stories in dermatology from the month of January.

ICYMI: Allergan Unveils AA Signature Program for Personalized Treatment

This innovative approach to multimodal aesthetics care was announced at IMCAS World Congress 2025.

Improving Hidradenitis Suppurativa Outcomes by Addressing Treatment Gaps

Patients with hidradenitis suppurativa experience knowledge gaps on effective treatments and addressing these gaps could help prevent tissue damage among patients.

Expanding Collaborations in the Fight Against Skin Cancer

There are numerous ways for dermatologists to get involved in initiatives from the Skin Cancer Foundation, according to Becky Kamowitz.

Study Explores Gaps in Patient-Doctor PsA Priorities

Researchers found that PsA patients prioritize fatigue, sleep issues, and uncertainty, often ranking them higher than doctors do.

Burn Care Disparities in Skin of Color

A recent study found standard burn assessment tools often fail to accurately evaluate injuries in darker skin tones, leading to misdiagnosis and delays.

Dermatology Times January 2025 Print Recap

Learn more about the in-depth topics covered in the January 2025 print issue of Dermatology Times.

What’s New in the Medicine Chest: Darier Disease

In an interview with Dermatology Times, Del Rosso shared the latest in the treatment landscape for patients with Darier disease.

Foundation for Ichthyosis & Related Skin Types Now Accepting Letters of Intent for 2025 Research Grant Program

Pilot and research grants may be awarded to research on keratinocyte biology and differentiation, genetics, biology of skin inflammation, itch, or other ichthyosis-related areas.

Q&A with Becky Kamowitz of the Skin Cancer Foundation: Expanding Partnerships and Advancing Awareness in 2025

As newly appointed Executive Director of the Foundation, Becky Kamowitz is combining public education with clinical needs in the fight against skin cancer.